Advertisement

Index by author

January 01, 1995; Volume 272,Issue 1

A

  1. Abdeen, O A

    1. Peripheral beta adrenergic blockade modifies airpuff startle-induced heart rate responses.
      O A Abdeen, B K Taylor, K L Youngblood and M P Printz
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 282-289;

  2. Aiba, T

    1. Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.
      T Aiba, Y Sakurai, S Tsukada and T Koizumi
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 94-99;

  3. Almawi, W

    1. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
      C Stevens, M Lipman, S Fabry, M Moscovitch-Lopatin, W Almawi, S Keresztes, M A Peppercorn and T B Strom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 399-406;

  4. Aposhian, M M

    1. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
      D Gonzalez-Ramirez, R M Maiorino, M Zuniga-Charles, Z Xu, K M Hurlbut, P Junco-Munoz, M M Aposhian, R C Dart, J H Diaz Gama and D Echeverria
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 264-274;

  5. Arendt, R M

    1. Bidirectional effects of endogenous opioid peptides on endothelin release rates in porcine aortic endothelial cell culture: mediation by delta opioid receptor and opioid receptor antagonist-insensitive mechanisms.
      R M Arendt, M Schmoeckel, U Wilbert-Lampen, A Plasse, L Heucke and K Werdan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 1-7;

  6. Ator, N A

    1. Drug discrimination analysis of midazolam under a three-lever procedure: I. Dose-dependent differences in generalization and antagonism.
      C A Sannerud and N A Ator
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 100-111;

  7. Autore, G

    1. Acetic acid-induced colitis in normal and essential fatty acid deficient rats.
      N Mascolo, A A Izzo, G Autore, F M Maiello, G Di Carlo and F Capasso
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 469-475;

B

  1. Bach, T J

    1. Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin.
      G J Hom, S K Grant, G Wolfe, T J Bach, D E MacIntyre and N I Hutchinson
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 452-459;

  2. Baron, J A

    1. The effect of cigarette smoking on adrenal cortical hormones.
      J A Baron, R J Comi, V Cryns, T Brinck-Johnsen and N G Mercer
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 151-155;

  3. Bekavac, I

    1. Systemically administered cocaine selectively enhances long-latency responses of rat barrel field cortical neurons to vibrissae stimulation.
      I Bekavac and B D Waterhouse
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 333-342;

  4. Benincosa, L J

    1. Renal adaptation to altered dietary sulfate in rats.
      L J Benincosa, K Sagawa and M E Morris
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 248-255;

  5. Bergsbaken, C

    1. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
      P Y Law and C Bergsbaken
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 322-332;

  6. Bertolino, M

    1. 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
      I Zivkovic, D M Thompson, M Bertolino, D Uzunov, M DiBella, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 300-309;

  7. Bourrié, B

    1. In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.
      J M Derocq, B Bourrié, M Ségui, G Le Fur and P Casellas
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 224-230;

  8. Braeckman, R A

    1. Quantitation of the renal clearance of interleukin-2 using nephrectomized and ureter-ligated rats.
      J A Gibbons, Z P Luo, E R Hannon, R A Braeckman and J D Young
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 119-125;

  9. Brinck-Johnsen, T

    1. The effect of cigarette smoking on adrenal cortical hormones.
      J A Baron, R J Comi, V Cryns, T Brinck-Johnsen and N G Mercer
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 151-155;

  10. Burnett, J P

    1. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
      M A Desai, J P Burnett, P L Ornstein and D D Schoepp
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 38-43;

  11. Burrier, R E

    1. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
      R E Burrier, A A Smith, D G McGregor, L M Hoos, D L Zilli and H R Davis
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 156-163;

  12. Bye, L S

    1. Characterization of the cloned human mu opioid receptor.
      K Raynor, H Kong, A Mestek, L S Bye, M Tian, J Liu, L Yu and T Reisine
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 423-428;

C

  1. Campbell, S

    1. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
      D A Schwinn, G I Johnston, S O Page, M J Mosley, K H Wilson, N P Worman, S Campbell, M D Fidock, L M Furness and D J Parry-Smith
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 134-142;

  2. Capasso, F

    1. Acetic acid-induced colitis in normal and essential fatty acid deficient rats.
      N Mascolo, A A Izzo, G Autore, F M Maiello, G Di Carlo and F Capasso
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 469-475;

  3. Caruncho, H J

    1. gamma-Aminobutyric acid gating of Cl- channels in recombinant GABAA receptors.
      I Ducić, H J Caruncho, W J Zhu, S Vicini and E Costa
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 438-445;

  4. Casellas, P

    1. In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.
      J M Derocq, B Bourrié, M Ségui, G Le Fur and P Casellas
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 224-230;

  5. Chakder, S

    1. Distribution of VIP binding sites in opossum internal anal sphincter circular smooth muscle.
      S Chakder and S Rattan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 385-391;

  6. Chan, K

    1. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats.
      M Veljaca, C A Lesch, R Pllana, B Sanchez, K Chan and A Guglietta
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 417-422;

  7. Chang, R L

    1. High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats.
      L A Suchar, R L Chang, R T Rosen, J Lech and A H Conney
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 197-206;

  8. Chaplan, S R

    1. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists.
      T L Yaksh, J W Pogrel, Y W Lee and S R Chaplan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 207-214;

  9. Chaudhry, A

    1. Is the "atypical" beta-receptor in the rat stomach fundus the rat beta 3 receptor?
      M L Cohen, J G Granneman, A Chaudhry, K W Schenck, D J Cushing and A D Palkowitz
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 446-451;

  10. Chemtob, S

    1. Up-regulation of brain PGE2 and PGF2 alpha receptors and receptor-coupled second messengers by cyclooxygenase inhibition in newborn pigs.
      D Y Li, D R Varma and S Chemtob
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 15-19;

  11. Cherwinski, H M

    1. The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism.
      H M Cherwinski, D McCarley, R Schatzman, B Devens and J T Ransom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 460-468;

  12. Claro, E

    1. Neurotransmitter-specific profiles of inositol phosphates in rat brain cortex: relation to the mode of receptor activation of phosphoinositide phospholipase C.
      E Sarri, F Picatoste and E Claro
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 77-84;

  13. Cohen, M L

    1. 5-Hydroxytryptamine2B receptor signaling in rat stomach fundus: role of voltage-dependent calcium channels, intracellular calcium release and protein kinase C.
      D A Cox and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 143-150;
    2. Is the "atypical" beta-receptor in the rat stomach fundus the rat beta 3 receptor?
      M L Cohen, J G Granneman, A Chaudhry, K W Schenck, D J Cushing and A D Palkowitz
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 446-451;

  14. Comi, R J

    1. The effect of cigarette smoking on adrenal cortical hormones.
      J A Baron, R J Comi, V Cryns, T Brinck-Johnsen and N G Mercer
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 151-155;

  15. Conney, A H

    1. High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats.
      L A Suchar, R L Chang, R T Rosen, J Lech and A H Conney
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 197-206;

  16. Cook, J J

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
      J J Lynch, J J Cook, G R Sitko, M A Holahan, D R Ramjit, M J Mellott, M T Stranieri, I I Stabilito, G Zhang and R J Lynch
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 20-32;

  17. Costa, E

    1. 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
      I Zivkovic, D M Thompson, M Bertolino, D Uzunov, M DiBella, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 300-309;
    2. gamma-Aminobutyric acid gating of Cl- channels in recombinant GABAA receptors.
      I Ducić, H J Caruncho, W J Zhu, S Vicini and E Costa
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 438-445;

  18. Cox, D A

    1. 5-Hydroxytryptamine2B receptor signaling in rat stomach fundus: role of voltage-dependent calcium channels, intracellular calcium release and protein kinase C.
      D A Cox and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 143-150;

  19. Coy, D H

    1. Interaction of galanin fragments with galanin receptors on isolated smooth muscle cells from guinea pig stomach: identification of a novel galanin receptor subtype.
      Z F Gu, T K Pradhan, D H Coy and R T Jensen
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 371-378;

  20. Crabbe, J

    1. Dose- and duration-dependent tolerance to rotational effects of apomorphine in a rat model of Parkinsonism.
      S Gancher, J Crabbe, A Garland, E Lea and W Woodward
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 275-281;

  21. Cryns, V

    1. The effect of cigarette smoking on adrenal cortical hormones.
      J A Baron, R J Comi, V Cryns, T Brinck-Johnsen and N G Mercer
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 151-155;

  22. Cushing, D J

    1. Is the "atypical" beta-receptor in the rat stomach fundus the rat beta 3 receptor?
      M L Cohen, J G Granneman, A Chaudhry, K W Schenck, D J Cushing and A D Palkowitz
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 446-451;

D

  1. Dart, R C

    1. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
      D Gonzalez-Ramirez, R M Maiorino, M Zuniga-Charles, Z Xu, K M Hurlbut, P Junco-Munoz, M M Aposhian, R C Dart, J H Diaz Gama and D Echeverria
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 264-274;

  2. Davis, H R

    1. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
      R E Burrier, A A Smith, D G McGregor, L M Hoos, D L Zilli and H R Davis
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 156-163;

  3. Derocq, J M

    1. In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.
      J M Derocq, B Bourrié, M Ségui, G Le Fur and P Casellas
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 224-230;

  4. Desai, M A

    1. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
      M A Desai, J P Burnett, P L Ornstein and D D Schoepp
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 38-43;

  5. Devens, B

    1. The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism.
      H M Cherwinski, D McCarley, R Schatzman, B Devens and J T Ransom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 460-468;

  6. Diaz Gama, J H

    1. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
      D Gonzalez-Ramirez, R M Maiorino, M Zuniga-Charles, Z Xu, K M Hurlbut, P Junco-Munoz, M M Aposhian, R C Dart, J H Diaz Gama and D Echeverria
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 264-274;

  7. DiBella, M

    1. 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
      I Zivkovic, D M Thompson, M Bertolino, D Uzunov, M DiBella, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 300-309;

  8. Di Carlo, G

    1. Acetic acid-induced colitis in normal and essential fatty acid deficient rats.
      N Mascolo, A A Izzo, G Autore, F M Maiello, G Di Carlo and F Capasso
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 469-475;

  9. Ducić, I

    1. gamma-Aminobutyric acid gating of Cl- channels in recombinant GABAA receptors.
      I Ducić, H J Caruncho, W J Zhu, S Vicini and E Costa
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 438-445;

E

  1. Echeverria, D

    1. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
      D Gonzalez-Ramirez, R M Maiorino, M Zuniga-Charles, Z Xu, K M Hurlbut, P Junco-Munoz, M M Aposhian, R C Dart, J H Diaz Gama and D Echeverria
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 264-274;

F

  1. Fabry, S

    1. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
      C Stevens, M Lipman, S Fabry, M Moscovitch-Lopatin, W Almawi, S Keresztes, M A Peppercorn and T B Strom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 399-406;

  2. Fermini, B

    1. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes.
      Z Wang, B Fermini and S Nattel
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 184-196;

  3. Fidock, M D

    1. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
      D A Schwinn, G I Johnston, S O Page, M J Mosley, K H Wilson, N P Worman, S Campbell, M D Fidock, L M Furness and D J Parry-Smith
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 134-142;

  4. Flores-Murrieta, F J

    1. Relationship between pharmacokinetics and the analgesic effect of ketorolac in the rat.
      V Granados-Soto, F J López-Muñoz, E Hong and F J Flores-Murrieta
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 352-356;

  5. Fournié-Zaluski, M C

    1. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
      W Gonzalez Vera, M C Fournié-Zaluski, I Pham, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 343-351;

  6. Fraser, L

    1. Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.
      S W Larkin, L Fraser, H J Showell, T J Williams and J B Warren
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 392-398;

  7. Frederick, D

    1. 4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
      M P Kung, D Frederick, M Mu, Z P Zhuang and H F Kung
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 429-437;

  8. Furness, L M

    1. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
      D A Schwinn, G I Johnston, S O Page, M J Mosley, K H Wilson, N P Worman, S Campbell, M D Fidock, L M Furness and D J Parry-Smith
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 134-142;

  9. Furukawa, T

    1. Activation of endogenous thromboxane A2 biosynthesis mediates presynaptic inhibition by endothelin-3 of dog stellate ganglionic transmission.
      K Kushiku, H Ohjimi, H Yamada, T Kuwahara and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 70-76;

G

  1. Gancher, S

    1. Dose- and duration-dependent tolerance to rotational effects of apomorphine in a rat model of Parkinsonism.
      S Gancher, J Crabbe, A Garland, E Lea and W Woodward
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 275-281;

  2. Garland, A

    1. Dose- and duration-dependent tolerance to rotational effects of apomorphine in a rat model of Parkinsonism.
      S Gancher, J Crabbe, A Garland, E Lea and W Woodward
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 275-281;

  3. Gibbons, J A

    1. Quantitation of the renal clearance of interleukin-2 using nephrectomized and ureter-ligated rats.
      J A Gibbons, Z P Luo, E R Hannon, R A Braeckman and J D Young
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 119-125;

  4. Gonzalez-Ramirez, D

    1. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
      D Gonzalez-Ramirez, R M Maiorino, M Zuniga-Charles, Z Xu, K M Hurlbut, P Junco-Munoz, M M Aposhian, R C Dart, J H Diaz Gama and D Echeverria
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 264-274;

  5. Gonzalez Vera, W

    1. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
      W Gonzalez Vera, M C Fournié-Zaluski, I Pham, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 343-351;

  6. Granados-Soto, V

    1. Relationship between pharmacokinetics and the analgesic effect of ketorolac in the rat.
      V Granados-Soto, F J López-Muñoz, E Hong and F J Flores-Murrieta
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 352-356;

  7. Granneman, J G

    1. Is the "atypical" beta-receptor in the rat stomach fundus the rat beta 3 receptor?
      M L Cohen, J G Granneman, A Chaudhry, K W Schenck, D J Cushing and A D Palkowitz
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 446-451;

  8. Grant, S K

    1. Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin.
      G J Hom, S K Grant, G Wolfe, T J Bach, D E MacIntyre and N I Hutchinson
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 452-459;

  9. Grevelink, S A

    1. Vasorelaxant and second messenger effects of maxadilan.
      S A Grevelink, J Osborne, J Loscalzo and E A Lerner
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 33-37;

  10. Gu, Z F

    1. Interaction of galanin fragments with galanin receptors on isolated smooth muscle cells from guinea pig stomach: identification of a novel galanin receptor subtype.
      Z F Gu, T K Pradhan, D H Coy and R T Jensen
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 371-378;

  11. Guglietta, A

    1. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats.
      M Veljaca, C A Lesch, R Pllana, B Sanchez, K Chan and A Guglietta
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 417-422;

  12. Guidotti, A

    1. 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
      I Zivkovic, D M Thompson, M Bertolino, D Uzunov, M DiBella, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 300-309;

H

  1. Hannon, E R

    1. Quantitation of the renal clearance of interleukin-2 using nephrectomized and ureter-ligated rats.
      J A Gibbons, Z P Luo, E R Hannon, R A Braeckman and J D Young
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 119-125;

  2. Heucke, L

    1. Bidirectional effects of endogenous opioid peptides on endothelin release rates in porcine aortic endothelial cell culture: mediation by delta opioid receptor and opioid receptor antagonist-insensitive mechanisms.
      R M Arendt, M Schmoeckel, U Wilbert-Lampen, A Plasse, L Heucke and K Werdan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 1-7;

  3. Hewett, J A

    1. The coagulation system, but not circulating fibrinogen, contributes to liver injury in rats exposed to lipopolysaccharide from gram-negative bacteria.
      J A Hewett and R A Roth
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 53-62;

  4. Holahan, M A

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
      J J Lynch, J J Cook, G R Sitko, M A Holahan, D R Ramjit, M J Mellott, M T Stranieri, I I Stabilito, G Zhang and R J Lynch
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 20-32;

  5. Holsapple, M P

    1. Role of metabolism by esterase and cytochrome P-450 in cocaine-induced suppression of the antibody response.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, E J Kaminski and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 407-416;

  6. Hom, G J

    1. Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin.
      G J Hom, S K Grant, G Wolfe, T J Bach, D E MacIntyre and N I Hutchinson
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 452-459;

  7. Hong, E

    1. Relationship between pharmacokinetics and the analgesic effect of ketorolac in the rat.
      V Granados-Soto, F J López-Muñoz, E Hong and F J Flores-Murrieta
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 352-356;

  8. Hoos, L M

    1. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
      R E Burrier, A A Smith, D G McGregor, L M Hoos, D L Zilli and H R Davis
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 156-163;

  9. Hori, R

    1. Transport of oral cephalosporins by the H+/dipeptide cotransporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells.
      Y Tomita, M Takano, M Yasuhara, R Hori and K Inui
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 63-69;

  10. Hsu, P

    1. Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin.
      H Parfenova, P Hsu and C W Leffler
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 44-52;

  11. Hurlbut, K M

    1. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
      D Gonzalez-Ramirez, R M Maiorino, M Zuniga-Charles, Z Xu, K M Hurlbut, P Junco-Munoz, M M Aposhian, R C Dart, J H Diaz Gama and D Echeverria
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 264-274;

  12. Hutchinson, N I

    1. Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin.
      G J Hom, S K Grant, G Wolfe, T J Bach, D E MacIntyre and N I Hutchinson
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 452-459;

I

  1. Ikeda, M

    1. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex.
      T Kihara and M Ikeda
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 177-183;

  2. Inui, K

    1. Transport of oral cephalosporins by the H+/dipeptide cotransporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells.
      Y Tomita, M Takano, M Yasuhara, R Hori and K Inui
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 63-69;

  3. Izzo, A A

    1. Acetic acid-induced colitis in normal and essential fatty acid deficient rats.
      N Mascolo, A A Izzo, G Autore, F M Maiello, G Di Carlo and F Capasso
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 469-475;

J

  1. Jensen, R T

    1. Interaction of galanin fragments with galanin receptors on isolated smooth muscle cells from guinea pig stomach: identification of a novel galanin receptor subtype.
      Z F Gu, T K Pradhan, D H Coy and R T Jensen
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 371-378;

  2. Jeong, T C

    1. Role of metabolism by esterase and cytochrome P-450 in cocaine-induced suppression of the antibody response.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, E J Kaminski and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 407-416;

  3. Johnston, G I

    1. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
      D A Schwinn, G I Johnston, S O Page, M J Mosley, K H Wilson, N P Worman, S Campbell, M D Fidock, L M Furness and D J Parry-Smith
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 134-142;

  4. Jordan, S D

    1. Role of metabolism by esterase and cytochrome P-450 in cocaine-induced suppression of the antibody response.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, E J Kaminski and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 407-416;

  5. Junco-Munoz, P

    1. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
      D Gonzalez-Ramirez, R M Maiorino, M Zuniga-Charles, Z Xu, K M Hurlbut, P Junco-Munoz, M M Aposhian, R C Dart, J H Diaz Gama and D Echeverria
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 264-274;

K

  1. Kalman, J M

    1. Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart.
      J M Kalman, A M Tonkin and J M Power
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 85-93;

  2. Kaminski, E J

    1. Role of metabolism by esterase and cytochrome P-450 in cocaine-induced suppression of the antibody response.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, E J Kaminski and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 407-416;

  3. Kaneko, T

    1. Nitric oxide and prostaglandins in regulation of acid secretory response in rat stomach following injury.
      K Takeuchi, K Takehara, T Kaneko and S Okabe
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 357-363;

  4. Keresztes, S

    1. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
      C Stevens, M Lipman, S Fabry, M Moscovitch-Lopatin, W Almawi, S Keresztes, M A Peppercorn and T B Strom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 399-406;

  5. Kihara, T

    1. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex.
      T Kihara and M Ikeda
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 177-183;

  6. Koizumi, T

    1. Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.
      T Aiba, Y Sakurai, S Tsukada and T Koizumi
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 94-99;

  7. Kong, H

    1. Characterization of the cloned human mu opioid receptor.
      K Raynor, H Kong, A Mestek, L S Bye, M Tian, J Liu, L Yu and T Reisine
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 423-428;

  8. Kosten, T R

    1. Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans.
      A H Oliveto, M I Rosen, S W Woods and T R Kosten
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 231-241;

  9. Kung, H F

    1. 4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
      M P Kung, D Frederick, M Mu, Z P Zhuang and H F Kung
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 429-437;

  10. Kung, M P

    1. 4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
      M P Kung, D Frederick, M Mu, Z P Zhuang and H F Kung
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 429-437;

  11. Kuratani, K

    1. FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze.
      M Yamazaki, N Matsuoka, N Maeda, K Kuratani, Y Ohkubo and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 256-263;

  12. Kushiku, K

    1. Activation of endogenous thromboxane A2 biosynthesis mediates presynaptic inhibition by endothelin-3 of dog stellate ganglionic transmission.
      K Kushiku, H Ohjimi, H Yamada, T Kuwahara and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 70-76;

  13. Kuwahara, T

    1. Activation of endogenous thromboxane A2 biosynthesis mediates presynaptic inhibition by endothelin-3 of dog stellate ganglionic transmission.
      K Kushiku, H Ohjimi, H Yamada, T Kuwahara and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 70-76;

L

  1. Laboulandine, I

    1. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
      W Gonzalez Vera, M C Fournié-Zaluski, I Pham, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 343-351;

  2. Larkin, S W

    1. Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.
      S W Larkin, L Fraser, H J Showell, T J Williams and J B Warren
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 392-398;

  3. Law, P Y

    1. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
      P Y Law and C Bergsbaken
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 322-332;

  4. Le, H T

    1. Effect of alpha adrenergic agonist on the rabbit ear artery contraction to serotonin: enhanced response mediated by serotonergic1-like receptors.
      H Movahedi, H T Le, H M Spanggord and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 364-370;

  5. Lea, E

    1. Dose- and duration-dependent tolerance to rotational effects of apomorphine in a rat model of Parkinsonism.
      S Gancher, J Crabbe, A Garland, E Lea and W Woodward
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 275-281;

  6. Lech, J

    1. High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats.
      L A Suchar, R L Chang, R T Rosen, J Lech and A H Conney
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 197-206;

  7. Lee, Y W

    1. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists.
      T L Yaksh, J W Pogrel, Y W Lee and S R Chaplan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 207-214;

  8. Leffler, C W

    1. Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin.
      H Parfenova, P Hsu and C W Leffler
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 44-52;

  9. Le Fur, G

    1. In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.
      J M Derocq, B Bourrié, M Ségui, G Le Fur and P Casellas
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 224-230;

  10. Lerner, E A

    1. Vasorelaxant and second messenger effects of maxadilan.
      S A Grevelink, J Osborne, J Loscalzo and E A Lerner
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 33-37;

  11. Lesch, C A

    1. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats.
      M Veljaca, C A Lesch, R Pllana, B Sanchez, K Chan and A Guglietta
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 417-422;

  12. Li, D Y

    1. Up-regulation of brain PGE2 and PGF2 alpha receptors and receptor-coupled second messengers by cyclooxygenase inhibition in newborn pigs.
      D Y Li, D R Varma and S Chemtob
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 15-19;

  13. Lipman, M

    1. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
      C Stevens, M Lipman, S Fabry, M Moscovitch-Lopatin, W Almawi, S Keresztes, M A Peppercorn and T B Strom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 399-406;

  14. Little, H J

    1. Effects on ethanol withdrawal hyperexcitability of chronic treatment with a competitive N-methyl-D-aspartate receptor antagonist.
      T L Ripley and H J Little
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 112-118;

  15. Liu, J

    1. Characterization of the cloned human mu opioid receptor.
      K Raynor, H Kong, A Mestek, L S Bye, M Tian, J Liu, L Yu and T Reisine
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 423-428;

  16. López-Muñoz, F J

    1. Relationship between pharmacokinetics and the analgesic effect of ketorolac in the rat.
      V Granados-Soto, F J López-Muñoz, E Hong and F J Flores-Murrieta
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 352-356;

  17. Loscalzo, J

    1. Vasorelaxant and second messenger effects of maxadilan.
      S A Grevelink, J Osborne, J Loscalzo and E A Lerner
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 33-37;

  18. Luo, Z P

    1. Quantitation of the renal clearance of interleukin-2 using nephrectomized and ureter-ligated rats.
      J A Gibbons, Z P Luo, E R Hannon, R A Braeckman and J D Young
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 119-125;

  19. Lynch, J J

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
      J J Lynch, J J Cook, G R Sitko, M A Holahan, D R Ramjit, M J Mellott, M T Stranieri, I I Stabilito, G Zhang and R J Lynch
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 20-32;

  20. Lynch, R J

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
      J J Lynch, J J Cook, G R Sitko, M A Holahan, D R Ramjit, M J Mellott, M T Stranieri, I I Stabilito, G Zhang and R J Lynch
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 20-32;

M

  1. MacIntyre, D E

    1. Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin.
      G J Hom, S K Grant, G Wolfe, T J Bach, D E MacIntyre and N I Hutchinson
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 452-459;

  2. Madwed, J B

    1. Differential effects of L-NAME on blood pressure and heart rate responses to acetylcholine and bradykinin in cynomolgus primates.
      S M Weldon, R J Winquist and J B Madwed
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 126-133;

  3. Maeda, N

    1. FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze.
      M Yamazaki, N Matsuoka, N Maeda, K Kuratani, Y Ohkubo and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 256-263;

  4. Maiello, F M

    1. Acetic acid-induced colitis in normal and essential fatty acid deficient rats.
      N Mascolo, A A Izzo, G Autore, F M Maiello, G Di Carlo and F Capasso
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 469-475;

  5. Maiorino, R M

    1. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
      D Gonzalez-Ramirez, R M Maiorino, M Zuniga-Charles, Z Xu, K M Hurlbut, P Junco-Munoz, M M Aposhian, R C Dart, J H Diaz Gama and D Echeverria
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 264-274;

  6. Mascolo, N

    1. Acetic acid-induced colitis in normal and essential fatty acid deficient rats.
      N Mascolo, A A Izzo, G Autore, F M Maiello, G Di Carlo and F Capasso
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 469-475;

  7. Matsuoka, N

    1. FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze.
      M Yamazaki, N Matsuoka, N Maeda, K Kuratani, Y Ohkubo and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 256-263;

  8. Matulka, R A

    1. Role of metabolism by esterase and cytochrome P-450 in cocaine-induced suppression of the antibody response.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, E J Kaminski and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 407-416;

  9. McCarley, D

    1. The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism.
      H M Cherwinski, D McCarley, R Schatzman, B Devens and J T Ransom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 460-468;

  10. McGregor, D G

    1. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
      R E Burrier, A A Smith, D G McGregor, L M Hoos, D L Zilli and H R Davis
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 156-163;

  11. Mellott, M J

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
      J J Lynch, J J Cook, G R Sitko, M A Holahan, D R Ramjit, M J Mellott, M T Stranieri, I I Stabilito, G Zhang and R J Lynch
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 20-32;

  12. Mercer, N G

    1. The effect of cigarette smoking on adrenal cortical hormones.
      J A Baron, R J Comi, V Cryns, T Brinck-Johnsen and N G Mercer
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 151-155;

  13. Mestek, A

    1. Characterization of the cloned human mu opioid receptor.
      K Raynor, H Kong, A Mestek, L S Bye, M Tian, J Liu, L Yu and T Reisine
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 423-428;

  14. Michel, J B

    1. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
      W Gonzalez Vera, M C Fournié-Zaluski, I Pham, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 343-351;

  15. Morris, M E

    1. Renal adaptation to altered dietary sulfate in rats.
      L J Benincosa, K Sagawa and M E Morris
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 248-255;

  16. Moscovitch-Lopatin, M

    1. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
      C Stevens, M Lipman, S Fabry, M Moscovitch-Lopatin, W Almawi, S Keresztes, M A Peppercorn and T B Strom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 399-406;

  17. Mosley, M J

    1. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
      D A Schwinn, G I Johnston, S O Page, M J Mosley, K H Wilson, N P Worman, S Campbell, M D Fidock, L M Furness and D J Parry-Smith
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 134-142;

  18. Movahedi, H

    1. Effect of alpha adrenergic agonist on the rabbit ear artery contraction to serotonin: enhanced response mediated by serotonergic1-like receptors.
      H Movahedi, H T Le, H M Spanggord and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 364-370;

  19. Mu, M

    1. 4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
      M P Kung, D Frederick, M Mu, Z P Zhuang and H F Kung
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 429-437;

N

  1. Nakashima, M

    1. Isoproterenol causes hyperpolarization through opening of ATP-sensitive potassium channels in vascular smooth muscle of the canine saphenous vein.
      M Nakashima and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 379-384;

  2. Nattel, S

    1. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes.
      Z Wang, B Fermini and S Nattel
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 184-196;

O

  1. Ohjimi, H

    1. Activation of endogenous thromboxane A2 biosynthesis mediates presynaptic inhibition by endothelin-3 of dog stellate ganglionic transmission.
      K Kushiku, H Ohjimi, H Yamada, T Kuwahara and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 70-76;

  2. Ohkubo, Y

    1. FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze.
      M Yamazaki, N Matsuoka, N Maeda, K Kuratani, Y Ohkubo and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 256-263;

  3. Okabe, S

    1. Nitric oxide and prostaglandins in regulation of acid secretory response in rat stomach following injury.
      K Takeuchi, K Takehara, T Kaneko and S Okabe
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 357-363;

  4. Oliveto, A H

    1. Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans.
      A H Oliveto, M I Rosen, S W Woods and T R Kosten
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 231-241;

  5. Ornstein, P L

    1. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
      M A Desai, J P Burnett, P L Ornstein and D D Schoepp
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 38-43;

  6. Osborne, J

    1. Vasorelaxant and second messenger effects of maxadilan.
      S A Grevelink, J Osborne, J Loscalzo and E A Lerner
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 33-37;

P

  1. Page, S O

    1. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
      D A Schwinn, G I Johnston, S O Page, M J Mosley, K H Wilson, N P Worman, S Campbell, M D Fidock, L M Furness and D J Parry-Smith
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 134-142;

  2. Palkowitz, A D

    1. Is the "atypical" beta-receptor in the rat stomach fundus the rat beta 3 receptor?
      M L Cohen, J G Granneman, A Chaudhry, K W Schenck, D J Cushing and A D Palkowitz
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 446-451;

  3. Parfenova, H

    1. Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin.
      H Parfenova, P Hsu and C W Leffler
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 44-52;

  4. Parry-Smith, D J

    1. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
      D A Schwinn, G I Johnston, S O Page, M J Mosley, K H Wilson, N P Worman, S Campbell, M D Fidock, L M Furness and D J Parry-Smith
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 134-142;

  5. Patrick, G S

    1. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
      S P Welch, C Thomas and G S Patrick
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 310-321;

  6. Peppercorn, M A

    1. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
      C Stevens, M Lipman, S Fabry, M Moscovitch-Lopatin, W Almawi, S Keresztes, M A Peppercorn and T B Strom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 399-406;

  7. Pham, I

    1. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
      W Gonzalez Vera, M C Fournié-Zaluski, I Pham, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 343-351;

  8. Picatoste, F

    1. Neurotransmitter-specific profiles of inositol phosphates in rat brain cortex: relation to the mode of receptor activation of phosphoinositide phospholipase C.
      E Sarri, F Picatoste and E Claro
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 77-84;

  9. Pitts, D K

    1. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
      L Wang and D K Pitts
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 164-176;

  10. Plasse, A

    1. Bidirectional effects of endogenous opioid peptides on endothelin release rates in porcine aortic endothelial cell culture: mediation by delta opioid receptor and opioid receptor antagonist-insensitive mechanisms.
      R M Arendt, M Schmoeckel, U Wilbert-Lampen, A Plasse, L Heucke and K Werdan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 1-7;

  11. Pllana, R

    1. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats.
      M Veljaca, C A Lesch, R Pllana, B Sanchez, K Chan and A Guglietta
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 417-422;

  12. Pogrel, J W

    1. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists.
      T L Yaksh, J W Pogrel, Y W Lee and S R Chaplan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 207-214;

  13. Power, J M

    1. Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart.
      J M Kalman, A M Tonkin and J M Power
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 85-93;

  14. Pradhan, T K

    1. Interaction of galanin fragments with galanin receptors on isolated smooth muscle cells from guinea pig stomach: identification of a novel galanin receptor subtype.
      Z F Gu, T K Pradhan, D H Coy and R T Jensen
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 371-378;

  15. Printz, M P

    1. Peripheral beta adrenergic blockade modifies airpuff startle-induced heart rate responses.
      O A Abdeen, B K Taylor, K L Youngblood and M P Printz
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 282-289;

  16. Purdy, R E

    1. Effect of alpha adrenergic agonist on the rabbit ear artery contraction to serotonin: enhanced response mediated by serotonergic1-like receptors.
      H Movahedi, H T Le, H M Spanggord and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 364-370;

R

  1. Ramjit, D R

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
      J J Lynch, J J Cook, G R Sitko, M A Holahan, D R Ramjit, M J Mellott, M T Stranieri, I I Stabilito, G Zhang and R J Lynch
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 20-32;

  2. Ransom, J T

    1. The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism.
      H M Cherwinski, D McCarley, R Schatzman, B Devens and J T Ransom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 460-468;

  3. Rattan, S

    1. Distribution of VIP binding sites in opossum internal anal sphincter circular smooth muscle.
      S Chakder and S Rattan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 385-391;

  4. Raynor, K

    1. Characterization of the cloned human mu opioid receptor.
      K Raynor, H Kong, A Mestek, L S Bye, M Tian, J Liu, L Yu and T Reisine
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 423-428;

  5. Reisine, T

    1. Characterization of the cloned human mu opioid receptor.
      K Raynor, H Kong, A Mestek, L S Bye, M Tian, J Liu, L Yu and T Reisine
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 423-428;

  6. Rinken, A

    1. Subtype-specific changes in ligand binding properties after solubilization of muscarinic receptors from baculovirus-infected Sf9 insect cell membranes.
      A Rinken
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 8-14;

  7. Ripley, T L

    1. Effects on ethanol withdrawal hyperexcitability of chronic treatment with a competitive N-methyl-D-aspartate receptor antagonist.
      T L Ripley and H J Little
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 112-118;

  8. Roques, B P

    1. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
      W Gonzalez Vera, M C Fournié-Zaluski, I Pham, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 343-351;

  9. Rosen, M I

    1. Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans.
      A H Oliveto, M I Rosen, S W Woods and T R Kosten
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 231-241;

  10. Rosen, R T

    1. High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats.
      L A Suchar, R L Chang, R T Rosen, J Lech and A H Conney
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 197-206;

  11. Roth, R A

    1. The coagulation system, but not circulating fibrinogen, contributes to liver injury in rats exposed to lipopolysaccharide from gram-negative bacteria.
      J A Hewett and R A Roth
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 53-62;

S

  1. Sagawa, K

    1. Renal adaptation to altered dietary sulfate in rats.
      L J Benincosa, K Sagawa and M E Morris
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 248-255;

  2. Sakurai, Y

    1. Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.
      T Aiba, Y Sakurai, S Tsukada and T Koizumi
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 94-99;

  3. Sanchez, B

    1. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats.
      M Veljaca, C A Lesch, R Pllana, B Sanchez, K Chan and A Guglietta
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 417-422;

  4. Sannerud, C A

    1. Drug discrimination analysis of midazolam under a three-lever procedure: I. Dose-dependent differences in generalization and antagonism.
      C A Sannerud and N A Ator
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 100-111;

  5. Sarri, E

    1. Neurotransmitter-specific profiles of inositol phosphates in rat brain cortex: relation to the mode of receptor activation of phosphoinositide phospholipase C.
      E Sarri, F Picatoste and E Claro
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 77-84;

  6. Schachter, J B

    1. 3-Isobutyl-1-methylxanthine increases alpha-1-adrenergic receptor sensitivity and density in DDT1-MF2 smooth muscle cells.
      J B Schachter and B B Wolfe
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 215-223;

  7. Schatzman, R

    1. The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism.
      H M Cherwinski, D McCarley, R Schatzman, B Devens and J T Ransom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 460-468;

  8. Schenck, K W

    1. Is the "atypical" beta-receptor in the rat stomach fundus the rat beta 3 receptor?
      M L Cohen, J G Granneman, A Chaudhry, K W Schenck, D J Cushing and A D Palkowitz
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 446-451;

  9. Schmoeckel, M

    1. Bidirectional effects of endogenous opioid peptides on endothelin release rates in porcine aortic endothelial cell culture: mediation by delta opioid receptor and opioid receptor antagonist-insensitive mechanisms.
      R M Arendt, M Schmoeckel, U Wilbert-Lampen, A Plasse, L Heucke and K Werdan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 1-7;

  10. Schoepp, D D

    1. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
      M A Desai, J P Burnett, P L Ornstein and D D Schoepp
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 38-43;

  11. Schwinn, D A

    1. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
      D A Schwinn, G I Johnston, S O Page, M J Mosley, K H Wilson, N P Worman, S Campbell, M D Fidock, L M Furness and D J Parry-Smith
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 134-142;

  12. Ségui, M

    1. In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.
      J M Derocq, B Bourrié, M Ségui, G Le Fur and P Casellas
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 224-230;

  13. Showell, H J

    1. Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.
      S W Larkin, L Fraser, H J Showell, T J Williams and J B Warren
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 392-398;

  14. Sitko, G R

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
      J J Lynch, J J Cook, G R Sitko, M A Holahan, D R Ramjit, M J Mellott, M T Stranieri, I I Stabilito, G Zhang and R J Lynch
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 20-32;

  15. Smith, A A

    1. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
      R E Burrier, A A Smith, D G McGregor, L M Hoos, D L Zilli and H R Davis
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 156-163;

  16. Smith, F L

    1. Calcium modulation of morphine analgesia: role of calcium channels and intracellular pool calcium.
      F L Smith and D L Stevens
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 290-299;

  17. Spanggord, H M

    1. Effect of alpha adrenergic agonist on the rabbit ear artery contraction to serotonin: enhanced response mediated by serotonergic1-like receptors.
      H Movahedi, H T Le, H M Spanggord and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 364-370;

  18. Stabilito, I I

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
      J J Lynch, J J Cook, G R Sitko, M A Holahan, D R Ramjit, M J Mellott, M T Stranieri, I I Stabilito, G Zhang and R J Lynch
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 20-32;

  19. Stanulis, E D

    1. Role of metabolism by esterase and cytochrome P-450 in cocaine-induced suppression of the antibody response.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, E J Kaminski and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 407-416;

  20. Stevens, C

    1. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
      C Stevens, M Lipman, S Fabry, M Moscovitch-Lopatin, W Almawi, S Keresztes, M A Peppercorn and T B Strom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 399-406;

  21. Stevens, D L

    1. Calcium modulation of morphine analgesia: role of calcium channels and intracellular pool calcium.
      F L Smith and D L Stevens
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 290-299;

  22. Stranieri, M T

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
      J J Lynch, J J Cook, G R Sitko, M A Holahan, D R Ramjit, M J Mellott, M T Stranieri, I I Stabilito, G Zhang and R J Lynch
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 20-32;

  23. Strom, T B

    1. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
      C Stevens, M Lipman, S Fabry, M Moscovitch-Lopatin, W Almawi, S Keresztes, M A Peppercorn and T B Strom
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 399-406;

  24. Suchar, L A

    1. High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats.
      L A Suchar, R L Chang, R T Rosen, J Lech and A H Conney
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 197-206;

  25. Swaan, P W

    1. Carrier-mediated transport mechanism of foscarnet (trisodium phosphonoformate hexahydrate) in rat intestinal tissue.
      P W Swaan and J J Tukker
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 242-247;

T

  1. Takano, M

    1. Transport of oral cephalosporins by the H+/dipeptide cotransporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells.
      Y Tomita, M Takano, M Yasuhara, R Hori and K Inui
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 63-69;

  2. Takehara, K

    1. Nitric oxide and prostaglandins in regulation of acid secretory response in rat stomach following injury.
      K Takeuchi, K Takehara, T Kaneko and S Okabe
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 357-363;

  3. Takeuchi, K

    1. Nitric oxide and prostaglandins in regulation of acid secretory response in rat stomach following injury.
      K Takeuchi, K Takehara, T Kaneko and S Okabe
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 357-363;

  4. Taylor, B K

    1. Peripheral beta adrenergic blockade modifies airpuff startle-induced heart rate responses.
      O A Abdeen, B K Taylor, K L Youngblood and M P Printz
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 282-289;

  5. Thomas, C

    1. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
      S P Welch, C Thomas and G S Patrick
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 310-321;

  6. Thompson, D M

    1. 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
      I Zivkovic, D M Thompson, M Bertolino, D Uzunov, M DiBella, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 300-309;

  7. Tian, M

    1. Characterization of the cloned human mu opioid receptor.
      K Raynor, H Kong, A Mestek, L S Bye, M Tian, J Liu, L Yu and T Reisine
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 423-428;

  8. Tomita, Y

    1. Transport of oral cephalosporins by the H+/dipeptide cotransporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells.
      Y Tomita, M Takano, M Yasuhara, R Hori and K Inui
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 63-69;

  9. Tonkin, A M

    1. Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart.
      J M Kalman, A M Tonkin and J M Power
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 85-93;

  10. Tsukada, S

    1. Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.
      T Aiba, Y Sakurai, S Tsukada and T Koizumi
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 94-99;

  11. Tukker, J J

    1. Carrier-mediated transport mechanism of foscarnet (trisodium phosphonoformate hexahydrate) in rat intestinal tissue.
      P W Swaan and J J Tukker
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 242-247;

U

  1. Uzunov, D

    1. 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
      I Zivkovic, D M Thompson, M Bertolino, D Uzunov, M DiBella, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 300-309;

V

  1. Vanhoutte, P M

    1. Isoproterenol causes hyperpolarization through opening of ATP-sensitive potassium channels in vascular smooth muscle of the canine saphenous vein.
      M Nakashima and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 379-384;

  2. Varma, D R

    1. Up-regulation of brain PGE2 and PGF2 alpha receptors and receptor-coupled second messengers by cyclooxygenase inhibition in newborn pigs.
      D Y Li, D R Varma and S Chemtob
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 15-19;

  3. Veljaca, M

    1. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats.
      M Veljaca, C A Lesch, R Pllana, B Sanchez, K Chan and A Guglietta
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 417-422;

  4. Vicini, S

    1. gamma-Aminobutyric acid gating of Cl- channels in recombinant GABAA receptors.
      I Ducić, H J Caruncho, W J Zhu, S Vicini and E Costa
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 438-445;

W

  1. Wang, L

    1. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
      L Wang and D K Pitts
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 164-176;

  2. Wang, Z

    1. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes.
      Z Wang, B Fermini and S Nattel
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 184-196;

  3. Warren, J B

    1. Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.
      S W Larkin, L Fraser, H J Showell, T J Williams and J B Warren
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 392-398;

  4. Waterhouse, B D

    1. Systemically administered cocaine selectively enhances long-latency responses of rat barrel field cortical neurons to vibrissae stimulation.
      I Bekavac and B D Waterhouse
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 333-342;

  5. Welch, S P

    1. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
      S P Welch, C Thomas and G S Patrick
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 310-321;

  6. Weldon, S M

    1. Differential effects of L-NAME on blood pressure and heart rate responses to acetylcholine and bradykinin in cynomolgus primates.
      S M Weldon, R J Winquist and J B Madwed
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 126-133;

  7. Werdan, K

    1. Bidirectional effects of endogenous opioid peptides on endothelin release rates in porcine aortic endothelial cell culture: mediation by delta opioid receptor and opioid receptor antagonist-insensitive mechanisms.
      R M Arendt, M Schmoeckel, U Wilbert-Lampen, A Plasse, L Heucke and K Werdan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 1-7;

  8. Wilbert-Lampen, U

    1. Bidirectional effects of endogenous opioid peptides on endothelin release rates in porcine aortic endothelial cell culture: mediation by delta opioid receptor and opioid receptor antagonist-insensitive mechanisms.
      R M Arendt, M Schmoeckel, U Wilbert-Lampen, A Plasse, L Heucke and K Werdan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 1-7;

  9. Williams, T J

    1. Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.
      S W Larkin, L Fraser, H J Showell, T J Williams and J B Warren
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 392-398;

  10. Wilson, K H

    1. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
      D A Schwinn, G I Johnston, S O Page, M J Mosley, K H Wilson, N P Worman, S Campbell, M D Fidock, L M Furness and D J Parry-Smith
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 134-142;

  11. Winquist, R J

    1. Differential effects of L-NAME on blood pressure and heart rate responses to acetylcholine and bradykinin in cynomolgus primates.
      S M Weldon, R J Winquist and J B Madwed
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 126-133;

  12. Wolfe, B B

    1. 3-Isobutyl-1-methylxanthine increases alpha-1-adrenergic receptor sensitivity and density in DDT1-MF2 smooth muscle cells.
      J B Schachter and B B Wolfe
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 215-223;

  13. Wolfe, G

    1. Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin.
      G J Hom, S K Grant, G Wolfe, T J Bach, D E MacIntyre and N I Hutchinson
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 452-459;

  14. Woods, S W

    1. Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans.
      A H Oliveto, M I Rosen, S W Woods and T R Kosten
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 231-241;

  15. Woodward, W

    1. Dose- and duration-dependent tolerance to rotational effects of apomorphine in a rat model of Parkinsonism.
      S Gancher, J Crabbe, A Garland, E Lea and W Woodward
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 275-281;

  16. Worman, N P

    1. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
      D A Schwinn, G I Johnston, S O Page, M J Mosley, K H Wilson, N P Worman, S Campbell, M D Fidock, L M Furness and D J Parry-Smith
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 134-142;

X

  1. Xu, Z

    1. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
      D Gonzalez-Ramirez, R M Maiorino, M Zuniga-Charles, Z Xu, K M Hurlbut, P Junco-Munoz, M M Aposhian, R C Dart, J H Diaz Gama and D Echeverria
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 264-274;

Y

  1. Yaksh, T L

    1. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists.
      T L Yaksh, J W Pogrel, Y W Lee and S R Chaplan
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 207-214;

  2. Yamada, H

    1. Activation of endogenous thromboxane A2 biosynthesis mediates presynaptic inhibition by endothelin-3 of dog stellate ganglionic transmission.
      K Kushiku, H Ohjimi, H Yamada, T Kuwahara and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 70-76;

  3. Yamaguchi, I

    1. FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze.
      M Yamazaki, N Matsuoka, N Maeda, K Kuratani, Y Ohkubo and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 256-263;

  4. Yamazaki, M

    1. FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze.
      M Yamazaki, N Matsuoka, N Maeda, K Kuratani, Y Ohkubo and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 256-263;

  5. Yasuhara, M

    1. Transport of oral cephalosporins by the H+/dipeptide cotransporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells.
      Y Tomita, M Takano, M Yasuhara, R Hori and K Inui
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 63-69;

  6. Young, J D

    1. Quantitation of the renal clearance of interleukin-2 using nephrectomized and ureter-ligated rats.
      J A Gibbons, Z P Luo, E R Hannon, R A Braeckman and J D Young
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 119-125;

  7. Youngblood, K L

    1. Peripheral beta adrenergic blockade modifies airpuff startle-induced heart rate responses.
      O A Abdeen, B K Taylor, K L Youngblood and M P Printz
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 282-289;

  8. Yu, L

    1. Characterization of the cloned human mu opioid receptor.
      K Raynor, H Kong, A Mestek, L S Bye, M Tian, J Liu, L Yu and T Reisine
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 423-428;

Z

  1. Zhang, G

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
      J J Lynch, J J Cook, G R Sitko, M A Holahan, D R Ramjit, M J Mellott, M T Stranieri, I I Stabilito, G Zhang and R J Lynch
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 20-32;

  2. Zhu, W J

    1. gamma-Aminobutyric acid gating of Cl- channels in recombinant GABAA receptors.
      I Ducić, H J Caruncho, W J Zhu, S Vicini and E Costa
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 438-445;

  3. Zhuang, Z P

    1. 4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
      M P Kung, D Frederick, M Mu, Z P Zhuang and H F Kung
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 429-437;

  4. Zilli, D L

    1. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
      R E Burrier, A A Smith, D G McGregor, L M Hoos, D L Zilli and H R Davis
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 156-163;

  5. Zivkovic, I

    1. 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
      I Zivkovic, D M Thompson, M Bertolino, D Uzunov, M DiBella, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 300-309;

  6. Zuniga-Charles, M

    1. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
      D Gonzalez-Ramirez, R M Maiorino, M Zuniga-Charles, Z Xu, K M Hurlbut, P Junco-Munoz, M M Aposhian, R C Dart, J H Diaz Gama and D Echeverria
      Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 264-274;
Back to top

In this issue

Advertisement